CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Byotrol PLC Company Snapshot
Byotrol PLC operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Byotrol PLC with three other pharmaceutical manufacturers in Europe: Angle PLC (2017 sales of £498,000.00 [US$663,116.88 ] ), Summit Therapeutics PLC (£2.30 million [US$3.07 million] of which 100% was Drug Discovery), and Collagen Solutions PLC (£3.95 million [US$5.25 million] ).

Sales Analysis. During the year ended March of 2017, sales at Byotrol PLC were £3.13 million (US$4.16 million). This is an increase of 18.1% versus 2016, when the company's sales were £2.65 million. Despite this increase, sales are still below the level achieved in 2015, when Byotrol PLC reported sales of £3.25 million. Sales of Consumer saw an increase that was more than double the company's growth rate: sales were up 118.4% in 2017, from £527,521.00 to £1.15 million. Not all segments of Byotrol PLC experienced an increase in sales in 2017: sales of Professional fell 17.5% to £1.18 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Byotrol PLC
  Stock Performance Chart for Byotrol PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (10/13/2017): 3.88p
(Figures in Pounds Sterling)
1 Week 0.0%   13 Weeks -6.1%  
4 Weeks -15.2%   52 Weeks -10.3%  
 
Byotrol PLC Key Data:
  Ticker: BYOT Country: United Kingdom
  Exchanges: LON Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 3,127,182
(Year Ending Jan 2018).
Employees: 17
  Currency: Pounds Sterling Market Cap: 15,609,914
  Fiscal Yr Ends: March Shares Outstanding: 402,836,491
  Share Type: Ordinary Closely Held Shares: 83,643,043
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.